454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

Size: px
Start display at page:

Download "454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place"

Transcription

1 MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and can result in death. If a child accidentally uses ZUBSOLV, get emergency help right away. Read this Medicatin Guide befre yu start taking ZUBSOLV and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt take the place f talking t yur dctr. Talk t yur dctr r pharmacist if yu have questins abut ZUBSOLV. Share the imprtant infrmatin in this Medicatin Guide with members f yur husehld. What is the mst imprtant infrmatin I shuld knw abut ZUBSOLV? ZUBSOLV can cause serius and life-threatening breathing prblems. Call yur dctr right away r get emergency help if: Yu feel faint, dizzy, r cnfused. Yur breathing gets much slwer than is nrmal fr yu. These can be signs f an verdse r ther serius prblems. D nt switch frm ZUBSOLV t ther medicines that cntain buprenrphine withut talking with yur dctr. The amunt f buprenrphine in a dse f ZUBSOLV is nt the same as the amunt f buprenrphine in ther medicines that cntain buprenrphine. Yur dctr will prescribe a starting dse f buprenrphine that may be different than ther buprenrphine cntaining medicines yu may have been taking. ZUBSOLV cntains an piid that can cause physical dependence. D nt stp taking ZUBSOLV withut talking t yur dctr. Yu culd becme sick with uncmfrtable withdrawal signs and symptms because yur bdy has becme used t this medicine. Physical dependence is nt the same as drug addictin. ZUBSOLV is nt fr ccasinal r as needed use. An verdse, and even death, can happen if yu take benzdiazepines, sedatives, tranquilizers, r alchl while using ZUBSOLV. Ask yur dctr what yu shuld d if yu are taking ne f these. Call a dctr r get emergency help right away if yu: Feel sleepy and uncrdinated. Have blurred visin. Have slurred speech. Cannt think well r clearly. Have slwed reflexes and breathing. D nt inject ( sht-up ) ZUBSOLV. Injecting ZUBSOLV may cause life-threatening infectins and ther serius health prblems. Injecting ZUBSOLV may cause serius withdrawal symptms such as pain, cramps, vmiting, diarrhea, anxiety, sleep prblems, and cravings. In an emergency, have family members tell the emergency department staff that yu are physically dependent n an piid and are being treated with ZUBSOLV. What is ZUBSOLV? ZUBSOLV is a prescriptin medicine used t treat adults wh are addicted t piid drugs (either prescriptin r illegal); as part f a cmplete treatment prgram that als includes cunseling and behaviral therapy. ZUBSOLV is a cntrlled substance (CIII) because it cntains buprenrphine, which can be a target fr peple wh abuse prescriptin medicines r street drugs. Keep yur ZUBSOLV in a safe place t prtect it frm theft. Never give yur ZUBSOLV t anyne else; it can cause death r harm them. Selling r giving away this medicine is against the law. It is nt knwn if ZUBSOLV is safe r effective in children. Wh shuld nt take ZUBSOLV? D nt take ZUBSOLV if yu are allergic t buprenrphine r nalxne. What shuld I tell my dctr befre taking ZUBSOLV? ZUBSOLV may nt be right fr yu. Befre taking ZUBSOLV, tell yur dctr if yu:

2 Have truble breathing r lung prblems. Have an enlarged prstate gland (men). Have a head injury r brain prblem. Have prblems urinating. Have a curve in yur spine that affects yur breathing. Have liver r kidney prblems. Have gallbladder prblems. Have adrenal gland prblems. Have Addisn s disease. Have lw thyrid (hypthyridism). Have a histry f alchlism. Have mental prblems such as hallucinatins (seeing r hearing things that are nt there). Have any ther medical cnditin. Are pregnant r plan t becme pregnant. If yu take ZUBSOLV while pregnant, yur baby may have symptms f piid withdrawal r respiratry depressin at birth. Talk t yur dctr if yu are pregnant r plan t becme pregnant. Are breastfeeding r plan t breastfeed. ZUBSOLV can pass int yur breast milk and may harm yur baby. Talk t yur dctr abut the best way t feed yur baby if yu take ZUBSOLV. Mnitr yur baby fr increased sleepiness and breathing prblems. Tell yur dctr abut all the medicines yu take, including prescriptin and ver-the-cunter medicines, vitamins, and herbal supplements. ZUBSOLV may affect the way ther medicines wrk and ther medicines may affect hw ZUBSOLV wrks. Sme medicines may cause serius r life-threatening medical prblems when taken with ZUBSOLV. Smetimes the dses f certain medicines and ZUBSOLV may need t be changed if used tgether. D nt take any medicine while using ZUBSOLV until yu have talked with yur dctr. Yur dctr will tell yu if it is safe t take ther medicines while yu are using ZUBSOLV. Be especially careful abut taking ther medicines that may make yu sleepy, such as pain medicines, tranquilizers, sleeping pills, anxiety medicines, r antihistamines. Knw the medicines yu take. Keep a list f them t shw yur dctr r pharmacist each time yu get a new medicine. Hw shuld I take ZUBSOLV? Always take ZUBSOLV exactly as yur dctr tells yu. Yur dctr may change yur dse after seeing hw it affects yu. D nt change yur dse unless yur dctr tells yu t change it. D nt take ZUBSOLV mre ften than prescribed by yur dctr. Yu may be prescribed a dse f 2 r mre ZUBSOLV sublingual tablets at the same time. After inductin (yur first day f dsing), take ZUBSOLV 1 time a day. D nt cut, crush, break, chew r swallw the tablet. Yur dctr shuld shw yu hw t take ZUBSOLV the right way. Fllw the same instructins every time yu take a dse f ZUBSOLV. ZUBSOLV cmes in a blister pack with 10 blister units. Each blister unit cntains a ZUBSOLV tablet. Take the dse prescribed by yur dctr as fllws: Pull apart 1 f the blister units frm the blister pack by tearing alng the dtted lines (perfratins) until it is fully separated (See Figure A).

3 When the blister unit is fully separated, fld the single unit dwn at dtted line tward the blister (See Figure B). Slwly tear dwn at ntch t pen the blister unit (See Figure C). D nt push ZUBSOLV tablets thrugh the fil. This culd cause the tablet t break. As sn as yu remve yur prescribed dse f ZUBSOLV frm the blister pack place the tablet under yur tngue (See Figures D, E, and F). If mre than 1 tablet is required, place the tablets in different places under yur tngue at the same time.

4 Let the tablet disslve cmpletely. ZUBSOLV usually disslves in yur muth within 5 minutes. If yur muth is dry, take a sip f water t misten it. Spit ut r swallw the water and dry yur hands if they are wet befre yu place the ZUBSOLV tablet under yur tngue. While ZUBSOLV is disslving, d nt chew r swallw the tablet because the medicine will nt wrk as well. D nt eat r drink anything until the ZUBSOLV tablet has cmpletely disslved. Talking while the tablet is disslving can affect hw well the medicine in ZUBSOLV is absrbed. If yu miss a dse f ZUBSOLV, take yur medicine when yu remember. If it is almst time fr yur next dse, skip the missed dse and take the next dse at yur regular time. D nt take 2 dses at the same time unless yur dctr tells yu t. If yu are nt sure abut yur dsing, call yur dctr. D nt stp taking ZUBSOLV suddenly. Yu culd becme sick and have withdrawal symptms because yur bdy has becme used t the medicine. Physical dependence is nt the same as drug addictin. Yur dctr can tell yu mre abut the differences between physical dependence and drug addictin. T have fewer withdrawal symptms, ask yur dctr hw t stp using ZUBSOLV the right way. If yu take t much ZUBSOLV g t the nearest hspital emergency rm right away. What shuld I avid while taking ZUBSOLV? D nt drive, perate heavy machinery, r perfrm any ther dangerus activities until yu knw hw this medicatin affects yu. Buprenrphine can cause drwsiness and slw reactin times. This may happen mre ften in the first few weeks f treatment when yur dse is being changed, but can als happen if yu drink alchl r take ther sedative drugs when yu take ZUBSOLV. Yu shuld nt drink alchl while taking ZUBSOLV, as this can lead t lss f cnsciusness r even death. What are the pssible side effects f ZUBSOLV? ZUBSOLV can cause serius side effects, including: See What is the mst imprtant infrmatin I shuld knw abut ZUBSOLV? Respiratry prblems. Yu have a higher risk f death and cma if yu take ZUBSOLV with ther medicines, such as benzdiazepines. Sleepiness, dizziness, and prblems with crdinatin. Dependency r abuse. Liver prblems. Call yur dctr right away if yu ntice any f these signs f liver prblems: Yur skin r the white part f yur eyes turning yellw (jaundice), urine turning dark, stls turning light in clr, yu have less f an appetite, r yu have stmach (abdminal) pain r nausea. Yur dctr shuld d tests befre yu start taking and while yu take ZUBSOLV. Allergic reactin. Yu may have a rash, hives, swelling f yur face, wheezing, r lss f bld pressure and cnsciusness. Call a dctr r get emergency help right away. Opiid withdrawal. This can include: shaking, sweating mre than nrmal, feeling ht r cld mre than nrmal, runny nse, watery eyes, gse bumps, diarrhea, vmiting and muscle aches. Tell yur dctr if yu develp any f these symptms. Decrease in bld pressure. Yu may feel dizzy if yu get up t fast frm sitting r lying dwn. The mst cmmn side effects f ZUBSOLV include: Headache Increased sweating Decrease in sleep (insmnia) Nausea Cnstipatin Pain Vmiting Drug withdrawal syndrme Swelling f the extremities Tell yur dctr abut any side effect that bthers yu r that des nt g away. These are nt all the pssible side effects f ZUBSOLV. Fr mre infrmatin, ask yur dctr r pharmacist. Call yur dctr fr medical advice abut side effects. Yu may reprt side effects t the FDA at FDA Hw shuld I stre ZUBSOLV? Stre ZUBSOLV at rm temperature between 68 F t 77 F (20 C t 25 C). Keep ZUBSOLV in a safe place, ut f the sight and reach f children. Hw shuld I dispse f unused ZUBSOLV? Dispse f unused ZUBSOLV sublingual tablets as sn as yu n lnger need them. Flush unused tablets dwn the tilet.

5 General infrmatin abut the safe and effective use f ZUBSOLV. Medicines are smetimes prescribed fr purpses ther than thse listed in a Medicatin Guide. D nt use ZUBSOLV fr a cnditin fr which it was nt prescribed. D nt give ZUBSOLV t ther peple, even if they have the same symptms yu have. It may harm them and it is against the law. This Medicatin Guide summarizes the mst imprtant infrmatin abut ZUBSOLV. If yu wuld like mre infrmatin, talk t yur dctr r pharmacist. Yu can ask yur dctr r pharmacist fr infrmatin that is written fr health prfessinals. Fr mre infrmatin, call ZUBSOLV ( ). What are the ingredients in ZUBSOLV? Active Ingredients: buprenrphine and nalxne. Inactive Ingredients: mannitl, citric acid, sdium citrate, micrcrystalline cellulse, crscarmellse sdium, sucralse, silicn dixide, sdium stearyl fumarate, and menthl flavr. Manufactured fr and distributed by Orex US, Inc. Mrristwn, NJ USA ZUBSOLV is a licensed trademark f Orex US, Inc Orex US, Inc. All rights reserved. Printed in USA This Medicatin Guide has been apprved by the U.S. Fd and Drug Administratin. Revised: 12/2016

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII) MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.

More information

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away from children. If a child accidentally takes ZUBSOLV, this is a

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

MEDICATION GUIDE. (canagliflozin) Tablets

MEDICATION GUIDE. (canagliflozin) Tablets MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can

More information

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth.

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth. MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to: PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency

More information

Share the important information in this Medication Guide with members of your household.

Share the important information in this Medication Guide with members of your household. Medication Guide BUPRENORPHINE (BUE-pre-NOR-feen) and NALOXONE (nal-ox-one) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine and naloxone sublingual tablets in a secure place away from children.

More information

/0515 Medication Guide Aripiprazole Tablets

/0515 Medication Guide Aripiprazole Tablets 8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental

More information

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental

More information

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?

MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID? MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

o New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe.

o New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe. MEDICATION GUIDE FLUOXETINE CAPSULES, USP (fl xʹ e teen) 10 mg and 20 mg Read the Medicatin Guide that cmes with fluxetine capsules befre yu start taking it and each time yu get a refill. There may be

More information

Medication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection

Medication Guide SIGNIFOR [sig-na-for] (pasireotide) Injection Medicatin Guide SIGNIFOR [sig-na-fr] (pasiretide) Injectin Read this Medicatin Guide befre yu start using SIGNIFOR and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

MEDICATION GUIDE. (Interferon alfa-2b)

MEDICATION GUIDE. (Interferon alfa-2b) MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones.

Tendon problems can happen in people of all ages who take levofloxacin. Tendons are tough cords of tissue that connect muscles to bones. Medicatin Guide LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION, 25 mg/ml and LEVOFLOXACIN (LEE ve FLOX a sin) INJECTION in 5% Dextrse fr Intravenus Use Read this Medicatin Guide befre yu start taking levflxacin

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur

More information

Suicidal thoughts or actions:

Suicidal thoughts or actions: MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt

More information

Patient Information Leaflet

Patient Information Leaflet Page 25 Patient Information Leaflet PATIENT INFORMATION SUBOXONE (sub-ox-own) (buprenorphine HCl/naloxone HCl dihydrate, sublingual tablet) (C*) SUBUTEX (SUB-u-tex) (buprenorphine HCl, sublingual tablet)

More information

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use What is Rasuv? PATIENT INFORMATION RASUVO (ruh-soo-vh) (methtrexate) injectin, fr subcutaneus use Rasuv is a single-dse manually-triggered aut-injectr cntaining a prescriptin medicine, methtrexate. Methtrexate

More information

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets

MEDICATION GUIDE Levofloxacin (lee-voe-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets MEDICATION GUIDE Levflxacin (lee-ve-flox-a-sin) Tablets, USP 250 mg Tablets, 500 mg Tablets, and 750 mg Tablets Read this Medicatin Guide befre yu start taking levflxacin tablets and each time yu get a

More information

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP IMPORTANT: Keep oxycodone hydrochloride oral solution in a safe place away from children. Accidental use by a child is

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution IMPORTANT: Keep morphine sulfate oral solution in a safe place away from children. Accidental use by a child is a medical emergency

More information

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml) New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully

More information

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injectin, fr Subcutaneus Use Single-Dse Prefilled Syringe 150 mg Read this Instructins fr Use befre yu start using ZINBRYTA and each time yu get

More information

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and

More information

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

If you have any doubts or queries about your medication, please contact your doctor or pharmacist.

If you have any doubts or queries about your medication, please contact your doctor or pharmacist. Bayer plc Bayer Huse Strawberry Hill Newbury Berkshire RG14 1JA United Kingdm Telephne: +44 (0)1635 563 000 Facsimile: +44 (0)1635 563 393 Cmpany Web Site: http://www.bayer.c.uk Due t regulatry changes,

More information

Package leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate

Package leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Advantage EAP Employee Assistance Program

Advantage EAP Employee Assistance Program Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse

More information

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP) My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made

More information

What is the most important information I should know about Morphine Sulfate Oral Solution?

What is the most important information I should know about Morphine Sulfate Oral Solution? Medication Guide MORPHINE SULFATE (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution

MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution IMPORTANT: Do not give CODEINE Sulfate Oral Solution to a child to treat pain after tonsillectomy or adenoidectomy surgery. When you take CODEINE

More information

The Dizziness Handicap Inventory ( DHI )

The Dizziness Handicap Inventory ( DHI ) The Dizziness Handicap Inventry ( DHI ) P1. Des lking up increase yur prblem? Yes E2. Because f yur prblem, d yu feel frustrated? Yes F3. Because f yur prblem, d yu restrict yur travel fr business r recreatin?

More information

Call a healthcare provider right away if you have any of the following s ymptoms, es pecially if they are new, wors e, or worry you:

Call a healthcare provider right away if you have any of the following s ymptoms, es pecially if they are new, wors e, or worry you: MEDICATION GUIDE EMSAM [EM sam] (selegiline transdermal system) Read this Medicatin Guide carefully befre yu start using EMSAM and each time yu get a refill. There may be new infrmatin. This infrmatin

More information

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY YOU AND YOUR BODY DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY kk WHY IS THIS LEAFLET FOR YOU? Pancreatic excrine insufficiency (PEI) is imprtant t understand in diabetes care due t the changing functins

More information

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Imaging tests allow the cancer care team to check for cancer and other problems inside the body. IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu

More information

Do you have any of the symptoms listed below? Please circle all that apply.

Do you have any of the symptoms listed below? Please circle all that apply. D yu have any f the symptms listed belw? Please circle all that apply. Parkinsn s Symptms: Truble walking Falls Feet sticking t the flr Tremr Medicatins wearing ff Truble sleeping Vivid dreams Thrashing

More information

NEW PATIENT QUESTIONNAIRE-ADULT

NEW PATIENT QUESTIONNAIRE-ADULT 3700 WASHINGTON AVENUE EVANSVILLE, IN 47750 (812) 485-7680 NEW PATIENT QUESTIONNAIRE-ADULT PART 1. PATIENT INFORMATION Name Hme Phne Date f Birth Scial Security Number Wrk Phne Tday s Date Physicians Caring

More information

6. Never give SUBSYS to anyone else, even if they have the same symptoms you have. It may harm them or even cause death.

6. Never give SUBSYS to anyone else, even if they have the same symptoms you have. It may harm them or even cause death. Medication Guide SUBSYS (sub sis) CII (fentanyl) sublingual spray 100 mcg, 200 mcg, 400 mcg, 600 mcg, 800 mcg IMPORTANT: Do not use SUBSYS unless you are regularly using another opioid pain medicine around-the-clock

More information

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin

More information

Read all of this leaflet carefully before you start taking this medicine.

Read all of this leaflet carefully before you start taking this medicine. Due t regulatry changes, the cntent f the fllwing Patient Infrmatin Leaflet may vary frm the ne fund in yur medicine pack. Please cmpare the 'Leaflet prepared/revised date' twards the end f the leaflet

More information

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution Instructins fr Use INTRON A (In-trn-aye) (Interfern alfa-2b, recmbinant) Pwder fr Slutin Be sure that yu read, understand, and fllw these instructins befre injecting INTRON A. Yur healthcare prvider shuld

More information

Understanding Blood Counts

Understanding Blood Counts Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Asthma inhalers, medicines and treatments

Asthma inhalers, medicines and treatments Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

MEDICATION GUIDE. ACTIQ (AK-tik) CII (fentanyl citrate) oral transmucosal lozenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg

MEDICATION GUIDE. ACTIQ (AK-tik) CII (fentanyl citrate) oral transmucosal lozenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg MEDICATION GUIDE ACTIQ (AK-tik) CII (fentanyl citrate) oral transmucosal lozenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: Do not use ACTIQ unless you are regularly using another

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

Medication Guide. Medication Guide. Lazanda (La-ZAN-da) CII. (fentanyl) nasal spray 100 mcg, 400 mcg

Medication Guide. Medication Guide. Lazanda (La-ZAN-da) CII. (fentanyl) nasal spray 100 mcg, 400 mcg Medication Guide Medication Guide Lazanda (La-ZAN-da) CII (fentanyl) nasal spray 100 mcg, 400 mcg IMPORTANT: Do not use Lazanda unless you are regularly using another opioid pain medicine around-the-clock

More information

Understanding and Recognizing Anxiety

Understanding and Recognizing Anxiety Understanding and Recgnizing Anxiety Mst peple d nt recgnize their anxiety fr what it is, and instead think there is smething mre serius ging n. Myth: Reading, thinking, and learning abut anxiety will

More information

Before Your Visit: Mohs Skin Cancer Surgery

Before Your Visit: Mohs Skin Cancer Surgery Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with

More information

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth. DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that

More information

Package leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline

Package leaflet: Information for the user. CHAMPIX 0.5 mg film-coated tablets CHAMPIX 1 mg film-coated tablets Varenicline Package leaflet: Infrmatin fr the user CHAMPIX 0.5 mg film-cated tablets CHAMPIX 1 mg film-cated tablets Varenicline Read all f this leaflet carefully befre yu start taking this medicine because it cntains

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Glaucoma Interviews: Due Tuesday, May 22 nd

Glaucoma Interviews: Due Tuesday, May 22 nd Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant

More information

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,

More information

Orexo completes 1,080 patient REZOLV study and reports on improved treatment of opioid dependent patients

Orexo completes 1,080 patient REZOLV study and reports on improved treatment of opioid dependent patients Press release Orexo completes 1,080 patient REZOLV study and reports on improved treatment of opioid dependent patients Uppsala, Sweden, September 2, 2016 Orexo AB (publ.) announces that the REZOLV retrospective

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER (Sanfi-Aventis France), NT001 Suppliers submissin f the SRA apprved text Octber 2016 Name f the medicinal prduct Text bx PACKAGE LEAFLET: INFORMATION FOR THE USER NOTEZINE 100 mg, scred tablets Diethylcarbamazine

More information

PHARYNGO-OESOPHAGECTOMY

PHARYNGO-OESOPHAGECTOMY PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

PACKAGE LEAFLET INFORMATION FOR THE PATIENT

PACKAGE LEAFLET INFORMATION FOR THE PATIENT PACKAGE LEAFLET INFORMATION FOR THE PATIENT AMPICILLIN 125mg/5ml and 250mg/5ml ORAL SUSPENSION Please read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin

More information

MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension

MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension Read this Medication Guide before you start taking ONFI and each time you get a refill. There may be new information. This information

More information

Frequently asked questions: Influenza A (H1N1)v

Frequently asked questions: Influenza A (H1N1)v July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,

More information

CRANIOFACIAL RESECTION

CRANIOFACIAL RESECTION CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Continuous Nerve Blocks at Home

Continuous Nerve Blocks at Home What is a peripheral nerve blck? Making a difference in the lives f children, yuth and families Cntinuus Nerve Blcks at Hme This nerve blck is a way t treat and prevent pain after surgery. Yur child s

More information

Pediatric Health History Form

Pediatric Health History Form Pediatric Health Histry Frm Child s Name Date f Birth Mther s Name Father s Name Parent Cncerns - Please explain any ther cncerns r questins yu have abut yur child Des yur child have any allergies? Yes

More information

Tuscarawas County Health Department. Vivitrol Treatment Consent

Tuscarawas County Health Department. Vivitrol Treatment Consent Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide

More information

Patient Information Packet Date:

Patient Information Packet Date: Patient Infrmatin Packet Date: We knw paperwrk is nt fun, but thank yu s much fr taking the time! Last Name: First Name: MI Address: Phne: City State: Zip Cde: Mbile: D.O.B: / / Scial Security: / / Email:

More information

Introduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between.

Introduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between. 1 Drugs and Txins Intrductin Frensic txiclgy helps determine cause-and-effect relatinships between Expsure t a drug r ther substance and Txic r lethal effects frm that expsure 2 Frensic Science: Fundamentals

More information

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program? 3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:

More information

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone! Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please

More information

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised: Page 1 f 6 Subject: Range f Mtin Exercises Date Develped: 4/2010 PROTOCOL FOR: All trained staff PURPOSE: Range f Mtin (ROM) exercises are very imprtant if an individual has t stay in bed r in a wheelchair.

More information

MESSAGE GUIDE EBOLA VIRUS DISEASE. (For Health Promotion Team)

MESSAGE GUIDE EBOLA VIRUS DISEASE. (For Health Promotion Team) MESSAGE GUIDE EBOLA VIRUS DISEASE (Fr Health Prmtin Team) 1 NOTE This guide brings tgether the main messages that cmmunity health wrkers (CHWs) need t knw. All activities at the health facilities shuld

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List SESSION ANXIETY SYMPTOMS INTERVENTION 5 SESSION HANDOUTS Handut 5.1: Handut 5.2: Handut 5.3: Handut 5.4: Handut 5.5: Handut 5.6: When Yu Face Yur Fears STOP! Intrductin t Fighting Fear by Facing Fear The

More information

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

How should I take NUCYNTA oral solution?

How should I take NUCYNTA oral solution? Medication Guide NUCYNTA (new-sinn-tah) (tapentadol) oral solution, CII What is the most important information I should know about NUCYNTA oral solution? Get emergency help right away if you take too much

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

Name of procedure: Removal of submandibular salivary gland

Name of procedure: Removal of submandibular salivary gland Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information